Aptevo Therapeutics Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Aptevo Therapeutics Inc. (APVO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $830.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2020-03-25
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $830.00K.
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $830.00K.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $830.00K.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.08M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2019-12-31 | $830.00K 10-K · filed 2020-03-25 |
| 2018-12-31 | $830.00K 10-K · filed 2019-03-18 |
| 2017-12-31 | $830.00K 10-K · filed 2018-03-13 |
| 2016-12-31 | $2.08M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |